Gilead to buy a rival maker of AIDS drugs
Gilead Sciences Inc. has announced that it will buy Triangle Pharmaceuticals Inc. for $464 million in cash to expand its line of drugs to treat AIDS and hepatitis B.Gilead already sells an AIDS drug,
Gilead Sciences Inc. has announced that it will buy Triangle Pharmaceuticals Inc. for $464 million in cash to expand its line of drugs to treat AIDS and hepatitis B.Gilead already sells an AIDS drug,